BMO downgrades Replimune stock on FDA rejection concerns
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- Trump administration holds up NOAA grant funding
- Breaking Baz: ‘Paddington: The Musical’ Eyes 2027 Broadway Transfer After Olivier Awards Triumph, Reveals Producer Sonia Friedman
- 4 Takeaways From Orban’s Defeat in Hungary’s Election
- Exclusive-Chilean copper miner Codelco, contractors fined after deadly mine collapse
- JPMorgan sees UK banks lifting revenue guidance on rate repricing
- Craneware grants share option to chief legal officer
News from Other Countries
🇬🇧 United Kingdom
- Ghanaian footballer killed after armed attackers open fire at team bus
- The Masters that got away - Rose the nearly man again
- Britney Spears goes into rehab after driving under the influence arrest